Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging

NCT00623467 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

343

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Nervous System Diseases

Interventions

DRUG: Gadobutrol (Gadavist, Gadovist, BAY86-4875)

Sponsor

Bayer